An oral antisense oligonucleotide for PCSK9 inhibition
Gennemark, Peter, Walter, Katrin, Clemmensen, Niclas, Rekić, Dinko, Nilsson, Catarina A M, Knöchel, Jane, Hölttä, Mikko, Wernevik, Linda, Rosengren, Birgitta, Kakol-Palm, Dorota, Wang, Yanfeng, Yu, Rosie Z, Geary, Richard S, Riney, Stan J, Monia, Brett P, Isaksson, Rikard, Jansson-Löfmark, Rasmus, Rocha, Cristina S J, Lindén, Daniel, Hurt-Camejo, Eva, Crooke, Rosanne, Tillman, Lloyd, Rydén-Bergsten, Tina, Carlsson, Björn, Andersson, Ulf, Elebring, Marie, Tivesten, Anna, Davies, Nigel
Published in Science translational medicine (12.05.2021)
Published in Science translational medicine (12.05.2021)
Get more information
Journal Article
ETESIAN: A phase 2B study of the efficacy, safety and tolerability of AZD8233, a PCSK9-targeted antisense oligonucleotide, in patients with dyslipidemia
Hofherr, A., Schumi, J., Rekić, D., Knöchel, J., Nilsson, C.A.M., Rudvik, A., Hurt-Camejo, E., Wernevik, L., Rydén-Bergsten, T., Koren, M., Carlsson, B.C.L.
Published in Atherosclerosis (01.08.2022)
Published in Atherosclerosis (01.08.2022)
Get full text
Journal Article
Ethyl mercury toxicokinetics in humans after long-term repeated vaccine administration
Barregard, L., Rekic, D., Horvat, M., Elmberg, L., Lundh, T., Zachrisson, O.
Published in Toxicology letters (01.08.2011)
Published in Toxicology letters (01.08.2011)
Get full text
Journal Article
HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects (vol 50, pg 531, 2011)
Mukonzo, JK, Nanzigu, S, Rekic, D, Waako, P, Roshammar, D, Ashton, M, Ogwal-Okeng, J, Gustafsson, LL, Aklillu, E
Published in Clinical pharmacokinetics (2011)
Get full text
Published in Clinical pharmacokinetics (2011)
Journal Article
Erratum to: HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects
Mukonzo, J. K., Nanzigu, S., Rekić, D., Waako, P., Röshammar, D., Ashto, M., Ogwal-Okeng, J., Gustafsson, L. L., Aklillu, E.
Published in Clinical pharmacokinetics (2011)
Published in Clinical pharmacokinetics (2011)
Get full text
Journal Article
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data
Aoki, Yasunori, Cabrera, Claudia S, Ouwens, Mario, Bamberg, Krister, Nyström, Jenny, Raz, Itamar, Scirica, Benjamin M, Hamrén, Bengt, Greasley, Peter J, Rekic, Dinko
Published in PloS one (21.06.2022)
Published in PloS one (21.06.2022)
Get full text
Journal Article
HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz than Healthy Subjects
Mukonzo, Jackson K., Nanzigu, Sarah, Rekić, Dinko, Waako, Paul, Röshammar, Daniel, Ashton, Michael, Ogwal-Okeng, Jasper, Gustafsson, Lars L., Aklillu, Eleni
Published in Clinical pharmacokinetics (01.08.2011)
Published in Clinical pharmacokinetics (01.08.2011)
Get full text
Journal Article
Dose Finding Based on the Model Averaging Approach
Rekic, D, Florian, J, Johannesen, L, Zhao, L, Brar, S
Published in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Get full text
Published in JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Conference Proceeding
Bilirubin—A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
Rekić, Dinko, Clewe, Oskar, Röshammar, Daniel, Flamholc, Leo, Sönnerborg, Anders, Ormaasen, Vidar, Gisslén, Magnus, Äbelö, Angela, Ashton, Michael
Published in The AAPS journal (01.12.2011)
Published in The AAPS journal (01.12.2011)
Get full text
Journal Article